Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz(Medical University of South Carolina), G Grateau(Hôtel-Dieu de Paris), Pierre Ronco(Inserm), Bouke P. C. Hazenberg(University Medical Center Groningen), Philip N. Hawkins(The Royal Free Hospital), Orhan Sezer(Charité - Universitätsmedizin Berlin), Rodney H. Falk(Brigham and Women's Hospital), Giampaolo Merlini(University of Pavia), Philippe Moreau(Centre National de la Recherche Scientifique), Alan Solomon(University of Tennessee at Knoxville), Ray Comenzo(Tufts Medical Center), Jean Paul Fermand(Université Paris Cité), Vaishali Sanchorawala(Boston Medical Center)
Cited by 1,419
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k